Ophthalmology Market in Malaysia, Ophthalmology Industry

Ophthalmology Market in Malaysia, Ophthalmology Industry


Ophthalmology Market in Malaysia, Ophthalmology Industry

Lower Ophthalmology Costs in Malaysia: Ophthalmology cost in Malaysia is estimated to be comparatively less i.e. 40% less or even more than the spending made by a patient on an average for the same treatment in the US and European countries such as the UK, France, Germany and others. Low cost of Ophthalmology in Malaysia allows patients from the other countries to save a significant amount of money while benefiting from the one among the world-class medical treatment.
Hence, Malaysia is witnessing Growth in Number of Healthcare Travelers increased from 921 Thousand in 2016 to 1.2 Million in 2018, i.e. a growth of 14.1% during the period of just 2 years, i.e. 2016-18.

Diabetic Prevalence Rate in Adults: 12% of Overall Malaysian Population is suffering from diabetes in 2020. More than 18% Adults recorded Diabetes as on 2020, an increase from 11.2% in 2011, comparatively a higher proportion than other South East Asian Countries. Diabetes is a major health concern among Malaysians, and the prevalence of Type 2 diabetes (T2D) has escalated to more than 20% in adults above the age of 30 in 2020. Higher diabetic patients contributed to the growth of more patients who are suffering from Eye diseases like Diabetic Retinopathy, Cataract and Glaucoma.

Growing Share of Healthcare in GDP: GDP of Health Services in Private Sector increased from 8.0 Million in 2015 to around 12 Million in 2020P with a CAGR of 8.1% during 2015-20P whereas in Public Sector increased from 13.1 Million in 2015 to around 18.5 Million in 2020P with a CAGR of 7.2% during the same period. Gross Domestic Product (GDP) of health services provided an indication of the demand trends for health services including Ophthalmology Services in Public and Private Healthcare Settings in Malaysia.

Impact of COVID-19 on Malaysia Ophthalmology Market: COVID19 has severely impacted all the industries across the Globe. Eye related Elective Surgeries were stopped amidst the Movement Control Order (MCO) which was introduced by Federal Government of Malaysia to control COVID19 Pandemic effect on the Country. Guidelines were issued with respect to the Operations and Precautions to be followed across by the Ophthalmology Clinics. Guidelines majorly included timely Sterilization of Equipments, necessary Face Shields and Masks and Temperature Check of the Patient before they enter the clinic. Consultations and Surgeries declined in the Month of April, May and June as Customer footfall at the Clinics and Surgeries performed were reduced and only Patients with Severe Eye Problems could take the treatment.

Analysts at Ken Research in their latest publication “Malaysia Ophthalmology Market Outlook to 2025- Increase in Ophthalmic Surgeries & Consultations driven by Increasing Ageing Population Proportion and Ophthalmology Technological Advancements” observed that the Ophthalmology Market in Malaysia has been growing over the years as a result of Rising Number of Ophthalmologists, Growing Number of Clinics, Increasing Health Budget and Growth in Prevalence of Non Communicable Diseases such as Hypertension and Diabetes.

Malaysia Ophthalmology Market in terms of Number of Consultations and Number of Surgeries is expected to growth with a CAGR of 9.2% and 6.5% in the forecast period 2020-2025.

Key Segments Covered
Number of Consultations and Consultations Revenue
By Type of Specialty
Single Specialty Hospital/Clinic
Multi Specialty Hospital/Clinic
By Regions
Kuala Lumpur
By Ailment Type
Reduced Vision
Red Eyes
Eye Strain
General Check-Ups
Allergic Reactions
Deformities of Eye and Eye Lids
By Type of Clinic/Hospital
Public Hospitals/Clinics
Private Hospitals/Clinics
Number of Surgeries and Revenue from Surgeries
Type of Surgeries
Refractive Error
Retinal Disorders
Oculoplastic and Eye Lid Surgery
Malaysia Ophthalmology Market Companies Covered
ISEC Malaysia
Optimax Eye Specialist
Tunn Hussein Onn National Eye Hospital (THONEH)
Vista Eye Specialist
Top Vision Eye Specialist
Sunway Eye Centre
KPJ Centre for Sight
Oasis Eye Specialist
KL Eye Specialist
IKONIK Eye Specialist

Key Target Audience
Government and Regulatory Bodies
Industry Associations
Single Specialty Eye Clinics and Hospitals
Multi Specialty Eye Clinics and Hospitals
Eye Clinics
Medical Device Companies
Ophthalmology Device Instrument Companies

Time Period Captured in the Report:-
Historical Period: 2015-2020
Forecast Period: 2021-2025
Key Topics Covered in the Report
Malaysia Ophthalmology Market Overview
Malaysia Ophthalmology Market Ecosystem
South East Asian Countries Ophthalmology Market Cross Comparison
Cross Comparison- Major Ophthalmology Players in Malaysia
Malaysia Ophthalmology Revenue Streams
Malaysia Ophthalmology Market Landscape
Malaysia Ophthalmology Market Size
Malaysia Ophthalmology Market Segmentations 2020
Malaysia Ophthalmology Market Growth Drivers
Malaysia Ophthalmology Market Government Regulations
Malaysia Ophthalmology Market Trends & Developments
Malaysia Ophthalmology Issues and Challenges
Malaysia Ophthalmology Market Major Company Profiles
Malaysia Ophthalmology Clinic Investment Model
Malaysia Ophthalmology Market Future Market Size and Segmentations, 2020-2025F
Covid-19 Impact on Malaysia Ophthalmology Market
Analyst Recommendations
Case Studies

For More Information on the Research Report, Refer to Below Link:

Related Reports



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
[email protected]

Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana – 122001, India

Ken Research is a research based management consulting company. We provide strategic consultancy to aid clients on critical business perspective: strategy, marketing, organization, operations, technology, transformation, digital, advanced analytics, corporate finance, mergers & acquisitions and sustainability across all industries and geographies. We provide business intelligence and operational advisory in 300+ verticals underscoring disruptive technologies, emerging business models with precedent analysis and success case studies. Serving 70% of fortune 1000 companies globally, some of top consulting companies and Market leaders seek our intelligence to identify new revenue streams, customer/ vendor paradigm and pain points and due diligence on competition.

This release was published on openPR.


Source link

Robert Swift

Leave a Reply

Your email address will not be published. Required fields are marked *